AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA193219-04
The role of AXL-ABL axis in Barrett's carcinogenesis
National Institutes of Health
Grant: 5P50CA095103-14
Molecular Imaging & Targeted Therapeutics of Stem Cell-Derived Colon Cancer
FWCI
0.44
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords